Company / Shareholders' Equity
Mind Medicine (MindMed) Inc. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$332.3M
FY2025
5-year range
$78.1M / $332.3M
FY2021-FY2025
Trend
+37.6%
vs FY2024
Sector context
#124 of 213
Health Care
What the data says
At $332M, Mind Medicine (MindMed) Inc.'s shareholders' equity ranks #124 of 213 in the Health Care sector. Improved from $78M to $332M over the past 2 years.
Based on SEC 10-K filings.
$332M in FY2025 with a 5-year CAGR of +34.4%.
Improved from $78M to $332M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +30.1%
- 5-Year CAGR
- +34.4%
- 10-Year CAGR
- -
Sector benchmark
#124 of 213 in Health CareTop 58% of 213This company $332.3M Sector average $2.5B
▼
-87.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +34.4%, indicating consistent growth.
- In FY2025, shareholders' equity increased 37.6% year-over-year.
- Ranks #124 out of 213 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.70 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $332.3M | +37.6% |
| FY2024 | $241.4M | +209.0% |
| FY2023 | $78.1M | -48.2% |
| FY2022 | $150.9M | -0.5% |
| FY2021 | $151.7M | +99.9% |
| FY2020 | $75.9M | - |
| FY2019 | $0 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026